Impact Biomedical IBO
NYSE IBO
$5.46 -0.14 (-2.50%)
As of: Oct 1, 2026 · 3:57 PM EDT

Impact Biomedical (IBO) Operating Margin (2022 - 2026)

Updated

Impact Biomedical (IBO) posted Operating Margin of -23400.00% for Q2 2026, down 6928.57 percentage points from -16471.43% a year earlier but up 9300.00 percentage points from the prior quarter.

Analysis

Impact Biomedical (IBO) Operating Margin (2022 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Margin at Impact Biomedical was -14548.57%, up 37242.66 percentage points year-over-year; for FY2022, it came in at -6808.00%.

  • Quarterly Operating Margin has run from a low of -32700.00% in Q1 2026 to a high of -1500.00% in Q2 2022 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 28.21%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 37.86%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -3.52%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 32.97%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 20.57%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 34.95%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -133.21%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 37.40%
10 Impact Biomedical 598.41 Mn 601.61 Mn 2,000.00 -23,400.00%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -23,400.00%
Mar 31, 2026 -32,700.00%
Sep 30, 2025 -5,266.67%
Jun 30, 2025 -16,471.43%
Jun 30, 2022 -1,500.00%
API Access

Impact Biomedical Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=IBO&period=max&api_key=YOUR_API_KEY